Lexicon doubles authorized shares to 900M, adopts expanded 2026 equity plans

LEXICON PHARMACEUTICALS, INC.

Authorized common stock increased from 450M to 900M via Seventh Amended and Restated Certificate of Incorporation.
Stockholders approved 2026 Equity Incentive Plan, raising share reserve from 75M to 90M shares.
2026 Non-Employee Directors' Equity Incentive Plan approved, increasing pool from 4M to 6M shares.
All 408,434.7 shares of Series B Convertible Preferred converted into 20,421,735 common shares.
All director nominees elected and other proposals passed with strong majority votes (e.g., auditor ratification 99.3% for).

item 3.02 item 5.02 item 5.03 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LEXICON PHARMACEUTICALS, INC.: Increased authorized common stock from 450,000,000 to 900,000,000 (effective 2026-04-30).

Change: charter amendment
Effective: 2026-04-30

Exact text from the filing

The Seventh Amended and Restated Certificate of Incorporation increases the number of shares of our authorized Common Stock from 450,000,000 to 900,000,000.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-26-000065

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.